Lung Cancer Program

Lung Cancer Program

News & Stories

treatment choices finding a doctor team approach clinical trial pancreatic cancer diagnosis plan A genetics
Health Lab

Diagnosed with pancreatic cancer: Now what?

A pancreas cancer surgeon explains from Michigan Medicine how to find the best place for treatment, why that matters, and what to expect from the process.
ribbons in colorful colors lined up next to eachother
Health Lab

5-year survival rate has increased for all cancers, according to American Cancer Society

The American Cancer Society reports that mortality rates have continued to decline since the 1990s. N. Lynn Henry, of Michigan Medicine, answers questions about how factors such as healthy lifestyle choices, early screening and clinical trials have improved cancer survival rates.
lungs in blue and yellow spots floating
Health Lab

'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer

University of Michigan researchers found a new protein target PP2A and developed a drug to treat non-small cell lung cancers that have KRAS mutations.
Cancer Aware surrounded by a circle of multicolor ribbons
Cancer Aware

Understanding Prostate Biopsy

Those with an elevated prostate-specific antigen test are referred for a biopsy of their prostate to help diagnose prostate cancer or other prostate concerns. This can bring anxiety and discomfort for the patient.
Cancer Aware surrounded by a circle of multicolor ribbons
Cancer Aware

Focal therapy for prostate cancer

When treating for localized prostate cancer, surgery and radiation are usually what people hear about. However, there are other treatments that could be options under a heading of focal therapy. Dr. Andrew Wood, a urologic oncologist with U-M Health Rogel Cancer Center’s Weiser Center for Prostate Cancer talks about these options and which patients could benefit from them.
red background person laying on ground with machine over looking into body organs appearing on screen
Health Lab

Histotripsy stimulates the immune system to attack cancer cells outside the liver

The University of Michigan Health pioneered the treatment histotripsy for liver cancer, which is helping teach the immune system which cancer cells to attack.